throbber
From:
`To:
`
`Cc:
`Subject:
`Date:
`
`Malik, Jitty
`Fisher, Stanley; Mahaffy, Shaun; Pacchioli, Alissa M.; West, Christopher W.; Radeke, Heike Simone; Pacchioli,
`Alissa M.; Van Buskirk, Tedd W.; Teschner, Michael H.; Faegenburg, Russell W.; Wong, Jovial; Fundakowski,
`Claire (CFundakowski@winston.com); Fischer, Sarah; Zullow, Keith A
`Merck-Sitagliptin
`RE: IPR2020-00040, IPR2020-01045, IPR2020-01060, IPR2020-01072
`Thursday, July 2, 2020 8:51:25 AM
`
`Stan,
` 
`That will work.
` 
`Jitty
` 
`Jitendra (“Jitty”) Malik Ph.D.
`Partner
`Katten
`Katten Muchin Rosenman LLP
`550 S. Tryon Street, Suite 2900 | Charlotte, NC 28202-4213
`direct +1.704.344.3185
`jitty.malik@katten.com | katten.com
` 
`From: Fisher, Stanley <SFisher@wc.com> 
`Sent: Thursday, July 2, 2020 8:49 AM
`To: Malik, Jitty <jitty.malik@katten.com>; Mahaffy, Shaun <SMahaffy@wc.com>; Pacchioli, Alissa M.
`<alissa.pacchioli@katten.com>; West, Christopher W. <christopher.west@katten.com>; Radeke,
`Heike Simone <heike.radeke@katten.com>; Pacchioli, Alissa M. <alissa.pacchioli@katten.com>; Van
`Buskirk, Tedd W. <tvanbuskirk@lernerdavid.com>; Teschner, Michael H.
`<mteschner@lernerdavid.com>; Faegenburg, Russell W. <rfaegenburg@lernerdavid.com>; Wong,
`Jovial <JWong@winston.com>; Fundakowski, Claire (CFundakowski@winston.com)
`<CFundakowski@winston.com>; Fischer, Sarah <SFischer@goodwinlaw.com>; Zullow, Keith A
`<KZullow@goodwinlaw.com>
`Cc: Merck-Sitagliptin <MerckSitagliptin@wc.com>
`Subject: RE: IPR2020-00040, IPR2020-01045, IPR2020-01060, IPR2020-01072
` 
`EXTERNAL EMAIL – EXERCISE CAUTION
`Jitty,
` 
`Yes, can we say Thurs. Aug. 6?
` 
`Thanks,
`Stan
` 
`Stanley E. Fisher
`Williams & Connolly LLP
`725 Twelfth Street, N.W., Washington, DC 20005
`(P) 202-434-5289 |(F) 202-434-5029
`SFisher@wc.com | www.wc.com/sfisher
`
`Merck Sharp & Dohme Corp. Exhibit 2035
`Dr. Reddy’s Laboratories Inc. v. Merck Sharp and Dohme Corp.
`IPR2020-01060
`Page 1
`
`

`

` 
`From: Malik, Jitty <jitty.malik@katten.com> 
`Sent: Wednesday, July 01, 2020 10:55 AM
`To: Fisher, Stanley <SFisher@wc.com>; Mahaffy, Shaun <SMahaffy@wc.com>; Pacchioli, Alissa M.
`<alissa.pacchioli@katten.com>; West, Christopher W. <christopher.west@katten.com>; Radeke,
`Heike Simone <heike.radeke@katten.com>; Pacchioli, Alissa M. <alissa.pacchioli@katten.com>; Van
`Buskirk, Tedd W. <tvanbuskirk@lernerdavid.com>; Teschner, Michael H.
`<mteschner@lernerdavid.com>; Faegenburg, Russell W. <rfaegenburg@lernerdavid.com>; Wong,
`Jovial <JWong@winston.com>; Fundakowski, Claire (CFundakowski@winston.com)
`<CFundakowski@winston.com>; Fischer, Sarah <SFischer@goodwinlaw.com>; Zullow, Keith A
`<KZullow@goodwinlaw.com>
`Cc: Merck-Sitagliptin <MerckSitagliptin@wc.com>
`Subject: RE: IPR2020-00040, IPR2020-01045, IPR2020-01060, IPR2020-01072
` 
`Stan,
` 
`Does Merck have any availability August 5th-7th?
` 
`Jitty
` 
`Jitendra (“Jitty”) Malik Ph.D.
`Partner
`Katten
`Katten Muchin Rosenman LLP
`550 S. Tryon Street, Suite 2900 | Charlotte, NC 28202-4213
`direct +1.704.344.3185
`jitty.malik@katten.com | katten.com
` 
`From: Fisher, Stanley <SFisher@wc.com> 
`Sent: Wednesday, July 1, 2020 8:54 AM
`To: Malik, Jitty <jitty.malik@katten.com>; Mahaffy, Shaun <SMahaffy@wc.com>; Pacchioli, Alissa M.
`<alissa.pacchioli@katten.com>; West, Christopher W. <christopher.west@katten.com>; Radeke,
`Heike Simone <heike.radeke@katten.com>; Pacchioli, Alissa M. <alissa.pacchioli@katten.com>; Van
`Buskirk, Tedd W. <tvanbuskirk@lernerdavid.com>; Teschner, Michael H.
`<mteschner@lernerdavid.com>; Faegenburg, Russell W. <rfaegenburg@lernerdavid.com>; Wong,
`Jovial <JWong@winston.com>; Fundakowski, Claire (CFundakowski@winston.com)
`<CFundakowski@winston.com>; Fischer, Sarah <SFischer@goodwinlaw.com>; Zullow, Keith A
`<KZullow@goodwinlaw.com>
`Cc: Merck-Sitagliptin <MerckSitagliptin@wc.com>
`Subject: RE: IPR2020-00040, IPR2020-01045, IPR2020-01060, IPR2020-01072
` 
`EXTERNAL EMAIL – EXERCISE CAUTION
`Counsel,
` 
`Merck reserves all rights to oppose joinder, and if joinder is ordered, to seek party discovery in
`
`Merck Sharp & Dohme Corp. Exhibit 2035
`Dr. Reddy’s Laboratories Inc. v. Merck Sharp and Dohme Corp.
`IPR2020-01060
`Page 2
`
`

`

`advance of the deposition of Dr. Chorghade, along with a reasonable adjustment to the schedule to
`accommodate party discovery.  Do any of the other Petitioners (Teva, Sun, or DRL) intend to respond
`to my June 26 letter, which was an attempt to narrow the issues and potentially obviate an
`opposition to joinder?   
` 
`Assuming the Board denies the joinder motions, Merck has no objection to a remote deposition for
`Dr. Chorghade at the end of July.  July 22 does not work for Merck; we are available the following
`week on any of July 29-31.  Please let me know if one of those days works for Mylan to tentatively
`schedule Dr. Chorghade’s deposition. 
` 
`Thank you,
`Stan
` 
`Stanley E. Fisher
`Williams & Connolly LLP
`725 Twelfth Street, N.W., Washington, DC 20005
`(P) 202-434-5289 |(F) 202-434-5029
`SFisher@wc.com | www.wc.com/sfisher
` 
`From: Malik, Jitty <jitty.malik@katten.com> 
`Sent: Monday, June 29, 2020 1:35 PM
`To: Mahaffy, Shaun <SMahaffy@wc.com>; Pacchioli, Alissa M. <alissa.pacchioli@katten.com>; West,
`Christopher W. <christopher.west@katten.com>; Radeke, Heike Simone
`<heike.radeke@katten.com>; Pacchioli, Alissa M. <alissa.pacchioli@katten.com>; Van Buskirk, Tedd
`W. <tvanbuskirk@lernerdavid.com>; Teschner, Michael H. <mteschner@lernerdavid.com>;
`Faegenburg, Russell W. <rfaegenburg@lernerdavid.com>; Wong, Jovial <JWong@winston.com>;
`Fundakowski, Claire (CFundakowski@winston.com) <CFundakowski@winston.com>; Fischer, Sarah
`<SFischer@goodwinlaw.com>; Zullow, Keith A <KZullow@goodwinlaw.com>
`Cc: Merck-Sitagliptin <MerckSitagliptin@wc.com>
`Subject: RE: IPR2020-00040, IPR2020-01045, IPR2020-01060, IPR2020-01072
` 
`Counsel,
` 
`Mylan is in receipt of your letter.  To that end, and speaking only on behalf of Mylan, Mylan remains
`opposed to any change in the current schedule.  See IPR2020-00040 (Paper 32).  To that end, Dr.
`Chorghade will be made available for his deposition on July 22nd.  Due to the current COVID
`pandemic, and for the health and safety off all concerned, Dr. Chorghade will be made available only
`for a remote deposition.  Please let Mylan know if Merck has any objection to proceeding on this
`date.
` 
`Thanks,
` 
`Jitty
` 
`Jitendra (“Jitty”) Malik Ph.D.
`Partner
`
`Merck Sharp & Dohme Corp. Exhibit 2035
`Dr. Reddy’s Laboratories Inc. v. Merck Sharp and Dohme Corp.
`IPR2020-01060
`Page 3
`
`

`

`Katten
`Katten Muchin Rosenman LLP
`550 S. Tryon Street, Suite 2900 | Charlotte, NC 28202-4213
`direct +1.704.344.3185
`jitty.malik@katten.com | katten.com
` 
`From: Mahaffy, Shaun <SMahaffy@wc.com> 
`Sent: Friday, June 26, 2020 5:22 PM
`To: Malik, Jitty <jitty.malik@katten.com>; Pacchioli, Alissa M. <alissa.pacchioli@katten.com>; West,
`Christopher W. <christopher.west@katten.com>; Radeke, Heike Simone
`<heike.radeke@katten.com>; Malik, Jitty <jitty.malik@katten.com>; Pacchioli, Alissa M.
`<alissa.pacchioli@katten.com>; Van Buskirk, Tedd W. <tvanbuskirk@lernerdavid.com>; Teschner,
`Michael H. <mteschner@lernerdavid.com>; Faegenburg, Russell W.
`<rfaegenburg@lernerdavid.com>; Wong, Jovial <JWong@winston.com>; Fundakowski, Claire
`(CFundakowski@winston.com) <CFundakowski@winston.com>; Fischer, Sarah
`<SFischer@goodwinlaw.com>; Zullow, Keith A <KZullow@goodwinlaw.com>
`Cc: Merck-Sitagliptin <MerckSitagliptin@wc.com>
`Subject: IPR2020-00040, IPR2020-01045, IPR2020-01060, IPR2020-01072
` 
`EXTERNAL EMAIL – EXERCISE CAUTION
`Counsel,
` 
`Please see the attached correspondence.
` 
`Regards,
`Shaun
` 
`Shaun P. Mahaffy
`Associate | Williams & Connolly LLP
`725 Twelfth Street, N.W., Washington, DC 20005
`(P) 202-434-5554 | (F) 202-434-5029
`smahaffy@wc.com | www.wc.com
` 
`
`
`This message and any attachments are intended only for the addressee and may contain information that is
`privileged and confidential. If you have received this message in error, please do not read, use, copy, distribute, or
`disclose the contents of the message and any attachments. Instead, please delete the message and any attachments
`and notify the sender immediately. Thank you.
`===========================================================
`CONFIDENTIALITY NOTICE:
`This electronic mail message and any attached files contain information
`intended for the exclusive
`use of the individual or entity to whom it is addressed and may contain
`information that is
`proprietary, privileged, confidential and/or exempt from disclosure under
`applicable law. If you
`are not the intended recipient, you are hereby notified that any viewing,
`copying, disclosure or
`
`Merck Sharp & Dohme Corp. Exhibit 2035
`Dr. Reddy’s Laboratories Inc. v. Merck Sharp and Dohme Corp.
`IPR2020-01060
`Page 4
`
`

`

`distribution of this information may be subject to legal restriction or
`sanction. Please notify
`the sender, by electronic mail or telephone, of any unintended recipients
`and delete the original
`message without making any copies.
`===========================================================
`NOTIFICATION: Katten Muchin Rosenman LLP is an Illinois limited liability
`partnership that has
`elected to be governed by the Illinois Uniform Partnership Act (1997).
`===========================================================
`
`
`
`Merck Sharp & Dohme Corp. Exhibit 2035
`Dr. Reddy’s Laboratories Inc. v. Merck Sharp and Dohme Corp.
`IPR2020-01060
`Page 5
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket